Recent Acquisition Flow Contract Site Laboratory has been acquired by TD2 International as of February 2024, indicating potential opportunities to offer expanded preclinical and clinical services aligned with TD2's growth strategy.

Niche Expertise Specializing in flow cytometry for immunophenotyping and cellular functional assays, the company presents a valuable partnership prospect for organizations seeking advanced cellular analysis in drug development or diagnostics.

Growth Potential With a modest revenue between zero and one million dollars and a dedicated team of up to 50 employees, the firm offers opportunities for scalable collaborations to support their expansion and service offerings.

Market Expansion Positioned within the competitive biotech research space, the company’s capabilities can complement larger CRO firms like SGS and Eurofins, providing specialized services to attract clients requiring focused flow cytometry solutions.

Technology Utilization Utilizing platforms like WordPress and MySQL, the company demonstrates a modern digital infrastructure, which can facilitate targeted outreach, data integration, and streamlined client engagement efforts.